We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRX
4301
DELISTED
Chimerix, Inc.
CMRX
$13K ﹤0.01%
6,592
+3,209
+95% +$7.2K
ASAI
4302
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$13K ﹤0.01%
+795
New +$13K
CONN
4303
DELISTED
Conn's Inc.
CONN
$13K ﹤0.01%
1,952
-231
-11% -$2.2K
SHPW
4304
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$13K ﹤0.01%
2,579
+2,249
+682% +$16.2K
LVOX
4305
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$13K ﹤0.01%
4,571
+1,893
+71% +$3.99K
ELYS
4306
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$13K ﹤0.01%
26,670
+13,322
+100% +$8.47K
THRN
4307
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$13K ﹤0.01%
2,764
-4,438
-62% -$22.3K
GENY
4308
DELISTED
Principal Exchange-Traded Funds Principal Millennial Global Growth ETF
GENY
$13K ﹤0.01%
386
-76
-16% -$2.99K
BBIG
4309
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$13K ﹤0.01%
655
-1,270
-66% -$25.3K
SNRH
4310
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$13K ﹤0.01%
1,244
+269
+28% +$2.66K
LYLT
4311
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$13K ﹤0.01%
11,316
+3,721
+49% +$9.66K
ELVT
4312
DELISTED
Elevate Credit, Inc.
ELVT
$13K ﹤0.01%
12,311
+9,411
+325% +$17.1K
MSAC
4313
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$13K ﹤0.01%
1,319
-400
-23% -$3.94K
CLVS
4314
DELISTED
Clovis Oncology, Inc.
CLVS
$13K ﹤0.01%
10,689
-8,239
-44% -$12.8K
AMPI.U
4315
DELISTED
Advanced Merger Partners Inc Units
AMPI.U
$13K ﹤0.01%
1,314
ASZ
4316
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$13K ﹤0.01%
1,286
+535
+71% +$5.23K
LMPX
4317
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
$13K ﹤0.01%
1,452
+1,239
+582% +$8.07K
LBPH
4318
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$13K ﹤0.01%
3,306
+160
+5% +$591
AC
4319
DELISTED
Associated Capital Group
AC
$12K ﹤0.01%
320
-135
-30% -$5.29K
ADSE icon
4320
ADS-TEC Energy
ADSE
$880M
$12K ﹤0.01%
+1,629
New +$12.4K
AEYE icon
4321
AudioEye
AEYE
$101M
$12K ﹤0.01%
+2,293
New +$14K
AKBA icon
4322
Akebia Therapeutics
AKBA
$243M
$12K ﹤0.01%
37,823
-1,610
-4% -$632
BCS icon
4323
Barclays
BCS
$94.6B
$12K ﹤0.01%
1,908
-26,425
-93% -$204K
BIOX icon
4324
Bioceres Crop Solutions
BIOX
$27.8M
$12K ﹤0.01%
+942
New +$11.6K
CING icon
4325
Cingulate
CING
$64.7M
$12K ﹤0.01%
46
+31
+207% +$10.7K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.